12 companies

Novo Nordisk

Market Cap: DKK 1.6t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

NOVO B

DKK 344.65

7D

-8.0%

1Y

-56.8%

H. Lundbeck

Market Cap: DKK 42.9b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

HLUN B

DKK 45.54

7D

1.4%

1Y

5.7%

Genmab

Market Cap: DKK 112.8b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

GMAB

DKK 1,927.50

7D

5.6%

1Y

19.3%

Bavarian Nordic

Market Cap: DKK 17.9b

Develops, manufactures, and supplies life-saving vaccines.

BAVA

DKK 228.40

7D

-1.1%

1Y

2.5%

ChemoMetec

Market Cap: DKK 10.9b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

CHEMM

DKK 623.50

7D

-3.3%

1Y

56.8%

ALK-Abelló

Market Cap: DKK 45.5b

Operates as an allergy solutions company in Europe, North America, and internationally.

ALK B

DKK 208.20

7D

0.5%

1Y

21.7%

Gubra

Market Cap: DKK 6.5b

A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.

GUBRA

DKK 389.20

7D

-5.2%

1Y

-18.2%

Zealand Pharma

Market Cap: DKK 32.1b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

ZEAL

DKK 461.10

7D

1.2%

1Y

-43.1%

Strategic Partners

Market Cap: DKK 36.7m

Does not have significant operations.

STRAP

DKK 880.00

7D

-3.5%

1Y

-29.5%

Stenocare

Market Cap: DKK 43.0m

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally.

STENO

DKK 1.18

7D

3.5%

1Y

-42.2%

Pharma Equity Group

Market Cap: DKK 143.6m

Through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which current therapy is lacking or in need of improvement.

PEG

DKK 0.10

7D

-12.6%

1Y

-55.9%

BioPorto

Market Cap: DKK 599.2m

An in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the onset of disease states for management and therapies in Europe, North America, Asia, and internationally.

BIOPOR

DKK 1.30

7D

0.5%

1Y

-28.8%